232 related articles for article (PubMed ID: 12888106)
1. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism.
Mitrunen K; Hirvonen A
Mutat Res; 2003 Sep; 544(1):9-41. PubMed ID: 12888106
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer.
Thompson PA; Ambrosone C
J Natl Cancer Inst Monogr; 2000; (27):125-34. PubMed ID: 10963624
[TBL] [Abstract][Full Text] [Related]
3. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
Miyoshi Y; Noguchi S
Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in steroid hormone pathway genes and mammographic density.
Haiman CA; Hankinson SE; De Vivo I; Guillemette C; Ishibe N; Hunter DJ; Byrne C
Breast Cancer Res Treat; 2003 Jan; 77(1):27-36. PubMed ID: 12602902
[TBL] [Abstract][Full Text] [Related]
6. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
Tworoger SS; Chubak J; Aiello EJ; Ulrich CM; Atkinson C; Potter JD; Yasui Y; Stapleton PL; Lampe JW; Farin FM; Stanczyk FZ; McTiernan A
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women.
Martínez-Ramírez OC; Pérez-Morales R; Castro C; Flores-Díaz A; Soto-Cruz KE; Astorga-Ramos A; Gonsebatt ME; Casas L; Valdés-Flores M; Rubio J
Breast; 2013 Jun; 22(3):335-43. PubMed ID: 23000097
[TBL] [Abstract][Full Text] [Related]
9. Low penetrance genes associated with increased risk for breast cancer.
Weber BL; Nathanson KL
Eur J Cancer; 2000 Jun; 36(10):1193-9. PubMed ID: 10882856
[TBL] [Abstract][Full Text] [Related]
10. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
Greenlee H; Chen Y; Kabat GC; Wang Q; Kibriya MG; Gurvich I; Sepkovic DW; Bradlow HL; Senie RT; Santella RM; Ahsan H
Breast Cancer Res Treat; 2007 Mar; 102(1):111-7. PubMed ID: 16850246
[TBL] [Abstract][Full Text] [Related]
11. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen producing enzymes and mammary carcinogenesis: a review.
Subramanian A; Salhab M; Mokbel K
Breast Cancer Res Treat; 2008 Sep; 111(2):191-202. PubMed ID: 17934808
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes.
Corton JC; Bocos C; Moreno ES; Merritt A; Cattley RC; Gustafsson JA
Biochimie; 1997; 79(2-3):151-62. PubMed ID: 9209713
[TBL] [Abstract][Full Text] [Related]
14. Variability in estrogen-metabolizing genes and their association with genomic instability in untreated breast cancer patients and healthy women.
dos Santos RA; Teixeira AC; Mayorano MB; Carrara HH; de Andrade J; Takahashi CS
J Biomed Biotechnol; 2011; 2011():571784. PubMed ID: 21716904
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
Diergaarde B; Potter JD; Jupe ER; Manjeshwar S; Shimasaki CD; Pugh TW; Defreese DC; Gramling BA; Evans I; White E
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1751-9. PubMed ID: 18628428
[TBL] [Abstract][Full Text] [Related]
16. [LOH and genetic polymorphysms of breast cancer].
Utsumi T
Nihon Rinsho; 2012 Sep; 70 Suppl 7():71-5. PubMed ID: 23350368
[No Abstract] [Full Text] [Related]
17. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk and polymorphisms in genes involved in metabolism of estrogens (CYP17, HSD17beta1, COMT and MnSOD): possible protective role of MnSOD gene polymorphism Val/Ala and Ala/Ala in women that never breast fed.
Silva SN; Cabral MN; Bezerra de Castro G; Pires M; Azevedo AP; Manita I; Pina JE; Rueff J; Gaspar J
Oncol Rep; 2006 Oct; 16(4):781-8. PubMed ID: 16969494
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
20. Positive association of polymorphisms in estrogen biosynthesis gene, CYP19A1, and metabolism, GST, in breast cancer susceptibility.
Ramalhinho AC; Fonseca-Moutinho JA; Breitenfeld Granadeiro LA
DNA Cell Biol; 2012 Jun; 31(6):1100-6. PubMed ID: 22300440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
